<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table3" position="float"><label>Table 3.</label><caption><title>Summary of patient data</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Patient identity</th><th valign="top">Gender</th><th valign="top">Age (years)</th><th valign="top">Age at epilepsy onset (years)</th><th valign="top">Histopathological result</th><th valign="top">Antiepileptic drugs (pre-op)</th><th valign="top">Reconstructed SBs</th></tr></thead><tbody><tr><td valign="top">Hu_1</td><td valign="top">Female</td><td valign="top">36</td><td valign="top">4</td><td valign="top">GGL</td><td valign="top">LTG, LEV</td><td valign="top">53</td></tr><tr><td valign="top">Hu_2</td><td valign="top">Female</td><td valign="top">25</td><td valign="top">12</td><td valign="top">AHS</td><td valign="top">LTG</td><td valign="top">25</td></tr><tr><td valign="top">Hu_3</td><td valign="top">Female</td><td valign="top">25</td><td valign="top">23</td><td valign="top">GGL</td><td valign="top">Zebinix, LEV</td><td valign="top">25</td></tr><tr><td valign="top">Hu_4</td><td valign="top">Male</td><td valign="top">33</td><td valign="top">5</td><td valign="top">Gliosis</td><td valign="top">LEV, CBZ</td><td valign="top">25</td></tr><tr><td valign="top">Hu_5</td><td valign="top">Male</td><td valign="top">63</td><td valign="top">24</td><td valign="top">AHS</td><td valign="top">LEV, LTG, CBZ</td><td valign="top">22</td></tr><tr><td valign="top">Hu_6</td><td valign="top">Male</td><td valign="top">49</td><td valign="top">36</td><td valign="top">AHS</td><td valign="top">Vimpat, ZNS</td><td valign="top">-</td></tr></tbody></table><table-wrap-foot><fn><p>AHS: Ammon's horn sclerosis; GGL: Ganglioglioma; LEV: Levetiracetam; LTG: Lamotrigine; ZNS: Zonisamide; CBZ: Carbamazepine.</p></fn></table-wrap-foot></table-wrap>